Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AV5080
DRUG
2 trials
Sponsors
Viriom
Conditions
Influenza
Phase 2
Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza
Completed
NCT05095545
Viriom
Influenza
Start: 2017-11-13
End: 2019-08-30
Updated: 2021-10-27
Phase 3
Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza
NCT05093998
Viriom
Influenza
Start: 2022-01-15
End: 2023-07-31
Target: 700
Updated: 2021-10-26